0001145549-24-002089.txt : 20240118 0001145549-24-002089.hdr.sgml : 20240118 20240118141717 ACCESSION NUMBER: 0001145549-24-002089 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231130 FILED AS OF DATE: 20240118 DATE AS OF CHANGE: 20240118 PERIOD START: 20240831 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jacob Funds Inc. CENTRAL INDEX KEY: 0001090372 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-09447 FILM NUMBER: 24541294 BUSINESS ADDRESS: STREET 1: 727 2ND STREET, #106 CITY: HERMOSA BEACH STATE: CA ZIP: 90254 BUSINESS PHONE: 310-421-4942 MAIL ADDRESS: STREET 1: 727 2ND STREET, #106 CITY: HERMOSA BEACH STATE: CA ZIP: 90254 FORMER COMPANY: FORMER CONFORMED NAME: JACOB INTERNET FUND INC DATE OF NAME CHANGE: 20060106 FORMER COMPANY: FORMER CONFORMED NAME: JACOB INTERNET FUND DATE OF NAME CHANGE: 20060106 FORMER COMPANY: FORMER CONFORMED NAME: JACOB INTERNET FUND INC DATE OF NAME CHANGE: 19990713 0001090372 S000071967 Jacob Forward ETF C000227599 Jacob Forward ETF JFWD NPORT-P 1 primary_doc.xml NPORT-P false 0001090372 XXXXXXXX S000071967 C000227599 Jacob Funds Inc. 811-09447 0001090372 5493006PQB1DQR6P2S14 727 2nd Street #106 Hermosa Beach 90254 424-237-2164 Jacob Forward ETF S000071967 549300TQFVM16K87YK51 2024-08-31 2023-11-30 N 2461533.130000000000 20511.470000000000 2441021.660000000000 0.000000000000 0.000000000000 0.000000000000 0.000000000000 0.000000000000 0.000000000000 0.000000000000 0.000000000000 0.000000000000 0.000000000000 0.000000000000 0.000000000000 0.000000000000 N Tela Bio Inc N/A Tela Bio Inc 872381108 20425.000000000000 NS USD 106414.250000000000 4.3594144101 Long EC CORP US N 1 N N N Twilio Inc 5493004W8TRGD63APX93 Twilio Inc 90138F102 561.000000000000 NS USD 36285.480000000000 1.4864874243 Long EC CORP US N 1 N N N Zillow Group Inc 2549002XEELQDIR6FU05 Zillow Group Inc 98954M200 1469.000000000000 NS USD 60140.860000000000 2.4637577366 Long EC CORP US N 1 N N N Zhihu Inc N/A Zhihu Inc 98955N108 14500.000000000000 NS USD 10628.500000000000 0.4354119496 Long EC CORP CN N 1 N N Arcturus Therapeutics Holdings N/A Arcturus Therapeutics Holdings Inc 03969T109 625.000000000000 NS USD 14962.500000000000 0.6129605585 Long EC CORP US N 1 N N N Autohome Inc 529900NYB6ZGZN3MVT56 Autohome Inc 05278C107 1786.000000000000 NS USD 48775.660000000000 1.9981658008 Long EC CORP CN N 1 N N N Beam Therapeutics Inc N/A Beam Therapeutics Inc 07373V105 1315.000000000000 NS USD 36925.200000000000 1.5126944838 Long EC CORP US N 1 N N N Braze Inc 9845007B9EDBFD37C277 Braze Inc 10576N102 705.000000000000 NS USD 38732.700000000000 1.5867413483 Long EC CORP US N 1 N N N CareDx Inc 549300NQOFKL9NON0U06 CareDx Inc 14167L103 8810.000000000000 NS USD 85545.100000000000 3.5044793498 Long EC CORP US N 1 N N N Cloudflare Inc 5493007DY18BGNLDWU14 Cloudflare Inc 18915M107 2144.000000000000 NS USD 165409.600000000000 6.7762446647 Long EC CORP US N 1 N N N Codexis Inc N/A Codexis Inc 192005106 7912.000000000000 NS USD 18672.320000000000 0.7649387265 Long EC CORP US N 1 N N N Confluent Inc 254900MRZ83YWUV7SN74 Confluent Inc 20717M103 2323.000000000000 NS USD 49294.060000000000 2.0194028102 Long EC CORP US N 1 N N N Block Inc 549300OHIIUWSTIZME52 Block Inc 852234103 1769.000000000000 NS USD 112207.670000000000 4.5967502804 Long EC CORP US N 1 N N N CRISPR Therapeutics AG 506700O6IRRIQLT3W370 CRISPR Therapeutics AG N/A 844.000000000000 NS USD 56320.120000000000 2.3072355696 Long EC CORP CH N 1 N N Alphatec Holdings Inc 549300EZE8CQ8K65FS24 Alphatec Holdings Inc 02081G201 10933.000000000000 NS USD 129774.710000000000 5.3164096053 Long EC CORP US N 1 N N N Apellis Pharmaceuticals Inc 254900HS0ZFRXXSB9D42 Apellis Pharmaceuticals Inc 03753U106 413.000000000000 NS USD 22248.310000000000 0.9114343541 Long EC CORP US N 1 N N N Digital Turbine Inc 549300D0WZR1VI2QGB24 Digital Turbine Inc 25400W102 11582.000000000000 NS USD 53856.300000000000 2.2063016024 Long EC CORP US N 1 N N N DraftKings Inc N/A DraftKings Inc 26142V105 4450.000000000000 NS USD 170168.000000000000 6.9711794364 Long EC CORP US N 1 N N N Doximity Inc N/A Doximity Inc 26622P107 4370.000000000000 NS USD 101602.500000000000 4.1622940781 Long EC CORP US N 1 N N N First American Government Obli 549300R5MYM6VZF1RM44 First American Government Obligations Fund 31846V336 50315.320000000000 NS USD 50315.320000000000 2.0612402104 Long STIV RF US N 1 N N Harrow Inc N/A Harrow Inc 415858109 6183.000000000000 NS USD 57069.090000000000 2.3379182141 Long EC CORP US N 1 N N N HashiCorp Inc 549300XGOB9ZFQHMIP56 HashiCorp Inc 418100103 2843.000000000000 NS USD 60897.060000000000 2.4947365686 Long EC CORP US N 1 N N N Hello Group Inc 549300YMGLID32W48529 Hello Group Inc 423403104 5665.000000000000 NS USD 36595.900000000000 1.4992042307 Long EC CORP CN N 1 N N N Heron Therapeutics Inc 549300DR2I1DOPD2IX53 Heron Therapeutics Inc 427746102 71233.000000000000 NS USD 87616.590000000000 3.5893409483 Long EC CORP US N 1 N N N HUYA Inc 549300WPEZ00T1MABE80 HUYA Inc 44852D108 11519.000000000000 NS USD 39049.410000000000 1.5997158337 Long EC CORP CN N 1 N N N Ideaya Biosciences Inc 549300ULW08F62IJML11 Ideaya Biosciences Inc 45166A102 1333.000000000000 NS USD 41922.850000000000 1.7174304795 Long EC CORP US N 1 N N N Identiv Inc 5299008KH3C585Z0DS77 Identiv Inc 45170X205 15970.000000000000 NS USD 110512.400000000000 4.5273010810 Long EC CORP US N 1 N N N Impinj Inc 549300M26VGKSMMWWN17 Impinj Inc 453204109 353.000000000000 NS USD 29507.270000000000 1.2088082004 Long EC CORP US N 1 N N N Inspired Entertainment Inc 549300ZUGYK6NBIU6D69 Inspired Entertainment Inc 45782N108 12807.000000000000 NS USD 100663.020000000000 4.1238069145 Long EC CORP US N 1 N N N JOYY Inc 549300N6CHVU5CQZPW24 JOYY Inc 46591M109 353.000000000000 NS USD 13558.730000000000 0.5554530802 Long EC CORP SG N 1 N N N Krystal Biotech Inc 549300YONUY68210OE41 Krystal Biotech Inc 501147102 648.000000000000 NS USD 67541.040000000000 2.7669168655 Long EC CORP US N 1 N N N MongoDB Inc 549300TPTG69WKWE1Z37 MongoDB Inc 60937P106 260.000000000000 NS USD 108092.400000000000 4.4281622638 Long EC CORP US N 1 N N N Nextdoor Holdings Inc N/A Nextdoor Holdings Inc 65345M108 30758.000000000000 NS USD 49212.800000000000 2.0160738762 Long EC CORP US N 1 N N N OptimizeRx Corp N/A OptimizeRx Corp 68401U204 11607.000000000000 NS USD 110382.570000000000 4.5219824063 Long EC CORP US N 1 N N N Porch Group Inc 549300NXEI7CVW8IXQ90 Porch Group Inc 733245104 80530.000000000000 NS USD 122405.600000000000 5.0145233041 Long EC CORP US N 1 N N N Rover Group Inc N/A Rover Group Inc 77936F103 678.000000000000 NS USD 7417.320000000000 0.3038612939 Long EC CORP US N 1 N N N Schrodinger Inc/United States N/A Schrodinger Inc/United States 80810D103 1595.000000000000 NS USD 49588.550000000000 2.0314670211 Long EC CORP US N 1 N N N SoFi Technologies Inc 549300SW81JCMVZDDY09 SoFi Technologies Inc 83406F102 3738.000000000000 NS USD 27250.020000000000 1.1163366736 Long EC CORP US N 1 N N N 2024-01-17 Jacob Funds Inc. /s/ Ryan Jacob Jacob Funds Inc. President/Principal Executive Officer XXXX NPORT-EX 2 forward.htm NPORT-EX

Jacob Forward ETF
Schedule of Investments (+)
as of November 30, 2023 (Unaudited)

COMMON STOCKS - 99.9%
 
Shares
   
Value
 
Auto Dealers & Gasoline Stations - 2.0%
       
Autohome, Inc. - ADR
   
1,786
   
$
48,776
 
                 
Biological Products (No Diagnostic Substances) - 6.4%
         
Beam Therapeutics, Inc.(a)
   
1,315
     
36,925
 
CRISPR Therapeutics AG(a)(b)
   
770
     
51,382
 
Krystal Biotech, Inc.(a)
   
648
     
67,541
 
             
155,848
 
Business Services - 7.2%
         
Digital Turbine, Inc.(a)
   
11,582
     
53,856
 
OptimizeRx Corp.(a)
   
11,607
     
110,383
 
Zhihu, Inc. - ADR(a)(b)
   
14,500
     
10,629
 
             
174,868
 
Computer and Peripheral Equipment Manufacturing - 4.5%
         
Identiv, Inc.(a)
   
15,970
     
110,512
 
                 
Computer Processing & Data Preparation - 8.3%
         
Doximity, Inc. - Class A(a)
   
4,370
     
101,602
 
HUYA, Inc. - ADR(a)
   
11,519
     
39,048
 
JOYY, Inc. - ADR
   
353
     
13,559
 
Nextdoor Holdings, Inc.(a)
   
30,758
     
49,213
 
             
203,422
 
Computer Programming Services - 4.0%
         
HashiCorp, Inc. - Class A(a)
   
2,843
     
60,898
 
Twilio, Inc. - Class A(a)
   
561
     
36,285
 
             
97,183
 
Computer Programming, Data Processing, Etc. - 14.8%
         
Braze, Inc. - Class A(a)
   
705
     
38,733
 
Cloudflare, Inc. - Class A(a)
   
2,144
     
165,411
 
Confluent, Inc. - Class A(a)
   
2,323
     
49,294
 
MongoDB, Inc.(a)
   
260
     
108,092
 
             
361,530
 
Finance Services - 5.7%
         
Block, Inc.(a)
   
1,769
     
112,208
 
SoFi Technologies, Inc.(a)
   
3,738
     
27,250
 
             
139,458
 
Industrial Organic Chemicals - 0.8%
         
Codexis, Inc.(a)
   
7,912
     
18,672
 
                 
Medical Laboratories - 3.5%
         
CareDx, Inc.(a)
   
8,810
     
85,545
 
                 
Miscellaneous Amusement & Recreation - 11.3%
         
DraftKings, Inc. - Class A(a)
   
4,450
     
170,168
 
Inspired Entertainment, Inc.(a)
   
13,607
     
106,951
 
             
277,119
 
Personal Services - 1.8%
         
Hello Group, Inc. - ADR
   
5,665
     
36,596
 
Rover Group, Inc.(a)
   
678
     
7,417
 
             
44,013
 
Pharmaceutical Preparations - 11.2%
         
Apellis Pharmaceuticals, Inc.(a)
   
413
     
22,248
 
Arcturus Therapeutics Holdings, Inc.(a)
   
625
     
14,963
 
Harrow, Inc.(a)
   
6,183
     
57,069
 
Heron Therapeutics, Inc.(a)
   
71,233
     
87,616
 
Ideaya Biosciences, Inc.(a)
   
1,333
     
41,923
 
Schrodinger, Inc.(a)
   
1,595
     
49,589
 
             
273,408
 
Real Estate - 7.5%
         
Porch Group, Inc.(a)
   
80,530
     
122,405
 
Zillow Group, Inc. - Class C(a)
   
1,469
     
60,141
 
             
182,546
 
Semiconductors & Related Devices - 1.2%
         
Impinj, Inc.(a)
   
353
     
29,507
 
                 
Surgical & Medical Instruments & Apparatus - 9.7%
         
Alphatec Holdings, Inc.(a)
   
10,933
     
129,775
 
Tela Bio, Inc.(a)
   
20,425
     
106,414
 
             
236,189
 
TOTAL COMMON STOCKS (Cost $3,627,266)
     
2,438,596
 
                 
MONEY MARKET FUNDS - 0.1%
 
Shares
   
Value
 
First American Government Obligations Fund - Class X, 5.29%(c)
   
2,144
     
2,144
 
TOTAL MONEY MARKET FUNDS (Cost $2,144)
     
2,144
 
                 
COLLATERAL FOR SECURITIES ON LOAN - 2.0%
 
Shares
   
Value
 
First American Government Obligations Fund - Class X, 5.29%(c)
   
48,172
     
48,172
 
TOTAL COLLATERAL FOR SECURITIES ON LOAN (Cost $48,172)
     
48,172
 
                 
TOTAL INVESTMENTS - 102.0% (Cost $3,677,582)
   
$
2,488,912
 
Liabilities in Excess of Other Assets - (2.0)%
     
(47,857
)
TOTAL NET ASSETS - 100.0%
         
$
2,441,055
 

Percentages are stated as a percent of net assets.
 

ADR - American Depositary Receipt

(+)
Schedule of Investments is classified using the U.S. Securities and Exchange Commission’s Standard Industrial Classification (SIC) Code List.
(a)
Non-income producing security.
(b)
All or a portion of this security is on loan as of November 30, 2023. The total market value of these securities was $43,183 which represented 1.8% of net assets.
(c)
The rate shown represents the 7-day effective yield as of November 30, 2023.



 Jacob Forward ETF Fund Summary of Fair Value Exposure (Unaudited)

Investment securities traded on a national securities exchange are valued at their market value determined by their last sales price in the principal market in which these securities are normally traded (except those traded on the NASDAQ National Market and Capital Market exchanges which are valued at the NASDAQ Official Closing Price (“NOCP”)), unless there are no transactions on the valuation date, in which case they are valued at the mean between the closing bid and ask prices. Securities traded over-the-counter are valued at the last reported sales price unless there is no reported sales price, in which case the mean between the closing bid and ask prices is used.  Foreign securities, currencies and other assets denominated in foreign currencies are translated into U.S. dollars at the exchange rate of such currencies. Foreign equity securities are valued at the last sale price at the close of the exchange on which the security is principally traded. The Jacob Forward ETF (the "Fund") values foreign securities at fair value, using fair valuation procedures approved by the Board of Directors (the "Board"), taking into account the occurrence of events after the close of foreign markets in calculating the net asset value ("NAV"). In such cases, use of fair valuation can reduce the investor's ability to seek profit by estimating the Fund's NAV in advance of the time the NAV is calculated. The Board has retained an independent fair value pricing service to assist in valuing foreign securities held by the Fund. Debt securities with maturities of 60 days or less are valued at amortized cost, which approximates market value. Short-term securities with 60 days or less remaining to maturity are, unless conditions indicate otherwise, amortized to maturity based on their cost to the Fund if acquired within 60 days of maturity or, if already held by the Fund on the 60th day, based on the value determined on the 61st day.  If amortized cost does not approximate fair value, short-term securities are reported at fair value. When reliable market quotations are not readily available or a pricing service does not provide a valuation (or provides a valuation that in the judgement of the Adviser does not represent the security's fair value) or when, in the judgment of the Adviser, events have rendered the market value unreliable, a security is fair valued in good faith by the Adviser under valuation procedures approved by the Board.

The Fund adheres to fair valuation accounting standards which provide an authoritative definition of fair value and sets out a hierarchy for measuring fair value. These standards require disclosures about the various inputs and valuation techniques used to develop the measurements of fair value and a discussion in changes in valuation techniques and related inputs during the period. These standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy is organized into three levels based upon the assumptions (referred to as “inputs”) used in pricing the asset or liability. These standards state that “observable inputs” reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from independent sources and “unobservable inputs” reflect an entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability.

Various inputs are used in determining the value of the Fund’s investments. These inputs are summarized in the three broad levels listed below:

Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access.
Level 2 - Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.  These inputs may include quoted prices for the identical instrument in an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.
Level 3 - Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Fund's own assumptions about the assumptions a market participant would use in valuing the asset or liability, and based on the best information available.

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The following is a summary of the inputs used to value the Fund's investments as of November 30, 2023:

Jacob Forward ETF
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
Investments:
                       
  Common Stocks
 
$
2,438,596
   
$
   
$
   
$
2,438,596
 
  Money Market Funds
   
2,144
     
     
     
2,144
 
  Collateral for Securities on Loan(a)
   
48,172
     
     
     
48,172
 
Total Investments
 
$
2,488,912
   
$
   
$
   
$
2,488,912
 

Refer to the Schedule of Investments for industry classifications.

(a)
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. The fair value amounts presented in the table are intended to permit reconciliation of the fair value hierarchy to the amounts listed in the Schedule of Investments.